TRPV4通道介导膀癌细胞的增殖,迁移和化学抵抗
bioRxiv : the preprint server for biology
|June 12, 2025
概括
暂时受体潜在化物4型 (TRPV4) 通过增加细胞增殖和迁移驱动膀癌 (BLCA) 的进展. 向TRPV4可能为BLCA提供新的治疗策略,并克服化疗抵抗.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 膀癌 (BLCA) 是一种普遍存在的恶性瘤,治疗进展有限.
- 在BLCA病变发生过程中,短暂受体潜在类型4 (TRPV4) 的作用在很大程度上仍未被探索.
研究的目的:
- 研究TRPV4在BLCA组织中的表达及其在癌细胞增殖,迁移和化学抵抗中的功能作用.
- 评估TRPV4作为BLCA的潜在治疗点.
主要方法:
- 在BLCA数据库中对TRPV4表达的生物信息分析 (UALCAN,cBioPortal).
- 使用正常的人类泌尿管细胞 (SV-HUC-1) 和BLCA (T-24,UM-UC-3) 细胞进行功能测试,以评估流入,细胞增殖,迁移以及对TRPV4抑制和西斯治疗的反应.
主要成果:
- 在BLCA组织中,TRPV4的表达显著升高,特别是在早期和肌肉侵入性膀癌 (MIBC) 中.
- 与正常细胞相比,在BLCA细胞中观察到增强的TRPV4介导的流入,增加的细胞增殖和迁移.
- 药理上抑制TRPV4可以减少BLCA细胞的增殖和迁移.
- 在化学敏感细胞中,TRPV4被西斯降低了,但在耐化学性细胞中没有,这表明它在耐化学性中发挥了作用.
结论:
- TRPV4是BLCA进展的关键驱动因素,影响细胞增殖和迁移.
- TRPV4可能在赋予化学疗法耐药性的过程中发挥重要作用.
- 向TRPV4为膀癌治疗和克服药物耐药性提供了一个有希望的新疗法策略.
更多相关视频
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.2K
09:243-D Cell Culture System for Studying Invasion and Evaluating Therapeutics in Bladder Cancer
Published on: September 13, 2018
8.9K
相关概念视频
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Chemotaxis and Direction of Cell Migration
3.3K
Cells can detect chemical cues in their environment and reorganize the cytoskeleton to migrate toward them or away from them. This directional migration, called chemotaxis, is essential during embryogenesis and development, immune response, tissue repair and regeneration, and reproduction. These chemical cues can either attract or repel the cell's movement. For example, axon development is determined by a combination of chemoattractants and chemorepellents that direct the growing axon...
3.3K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
